Literature DB >> 19876617

Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395.

Kenneth P Smith1, Sanath Kumar, Manuel F Varela.   

Abstract

A putative multidrug efflux pump, EmrD-3, belonging to the major facilitator superfamily (MFS) of transporters and sharing homology with the Bcr/CflA subfamily, was identified in Vibrio cholerae O395. We cloned the emrD-3 gene and evaluated its role in antimicrobial efflux in a hypersensitive Escherichia coli strain. The efflux activity of this membrane protein resulted in lowering the intracellular concentration of ethidium. The recombinant plasmid carrying emrD-3 conferred enhanced resistance to several antimicrobials. Among the antimicrobials tested, the highest relative increase in minimum inhibitory concentration (MIC) of 102-fold was observed for linezolid (MIC = 256 microg/ml), followed by an 80.1-fold increase for tetraphenylphosphonium chloride (TPCL) (156.2 microg/ml), 62.5-fold for rifampin (MIC = 50 microg/ml), >30-fold for erythromycin (MIC = 50 microg/ml) and minocycline (MIC = 2 microg/ml), 20-fold for trimethoprim (MIC = 0.12 microg/ml), and 18.7-fold for chloramphenicol (MIC = 18.7 microg/ml). Among the fluorescent DNA-binding dyes, the highest relative increase in MIC of 41.7-fold was observed for ethidium bromide (125 microg/ml) followed by a 17.2-fold increase for rhodamine 6G (100 microg/ml). Thus, we demonstrate that EmrD-3 is a multidrug efflux pump of V. cholerae, the homologues of which are present in several Vibrio spp., some members of Enterobacteriaceae family, and Gram-positive Bacillus spp.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19876617      PMCID: PMC2809785          DOI: 10.1007/s00203-009-0521-8

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  49 in total

1.  The TetA(K) tetracycline/H(+) antiporter from Staphylococcus aureus: mutagenesis and functional analysis of motif C.

Authors:  S L Ginn; M H Brown; R A Skurray
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

Review 2.  Structure and function of multidrug transporters.

Authors:  H W van Veen; W N Konings
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

3.  The role of efflux in macrolide resistance.

Authors:  Ping Zhong; Virginia D. Shortridge
Journal:  Drug Resist Updat       Date:  2000-12       Impact factor: 18.500

4.  Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps.

Authors:  Jürgen A Bohnert; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 5.  Ins and outs of major facilitator superfamily antiporters.

Authors:  Christopher J Law; Peter C Maloney; Da-Neng Wang
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

Review 6.  Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes.

Authors:  Marilyn C Roberts
Journal:  FEMS Microbiol Lett       Date:  2008-04-09       Impact factor: 2.742

7.  Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamily.

Authors:  M F Varela; C E Sansom; J K Griffith
Journal:  Mol Membr Biol       Date:  1995 Oct-Dec       Impact factor: 2.857

8.  In vitro RNA synthesis with SP6 RNA polymerase.

Authors:  P A Krieg; D A Melton
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

9.  Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.

Authors:  J G Slatter; D J Stalker; K L Feenstra; I R Welshman; J B Bruss; J P Sams; M G Johnson; P E Sanders; M J Hauer; P E Fagerness; R P Stryd; G W Peng; E M Shobe
Journal:  Drug Metab Dispos       Date:  2001-08       Impact factor: 3.922

10.  Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance.

Authors:  Jie Feng; Andréanne Lupien; Hélène Gingras; Jessica Wasserscheid; Ken Dewar; Danielle Légaré; Marc Ouellette
Journal:  Genome Res       Date:  2009-04-06       Impact factor: 9.043

View more
  17 in total

Review 1.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Alejandro Pironti; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 3.  Emergence of antibiotic-resistant extremophiles (AREs).

Authors:  Prashant Gabani; Dhan Prakash; Om V Singh
Journal:  Extremophiles       Date:  2012-08-21       Impact factor: 2.395

4.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

5.  Mycobacterium smegmatis MSMEG_3705 encodes a selective major facilitator superfamily efflux pump with multiple roles.

Authors:  Zhen Zhang; Rui Wang; Jianping Xie
Journal:  Curr Microbiol       Date:  2015-02-20       Impact factor: 2.188

6.  LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.

Authors:  Jody L Floyd; Kenneth P Smith; Sanath H Kumar; Jared T Floyd; Manuel F Varela
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

7.  Bacteriophage-Mediated Risk Pathways Underlying the Emergence of Antimicrobial Resistance via Intrageneric and Intergeneric Recombination of Antibiotic Efflux Genes Across Natural populations of Human Pathogenic Bacteria.

Authors:  Ekaterine Gabashvili; Saba Kobakhidze; Tamar Chkhikvishvili; Leila Tabatadze; Rusudan Tsiklauri; Ketevan Dadiani; Mamuka Kotetishvili
Journal:  Microb Ecol       Date:  2021-09-01       Impact factor: 4.552

Review 8.  Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance.

Authors:  Meenal Chawla; Jyoti Verma; Rashi Gupta; Bhabatosh Das
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

Review 9.  Biochemistry of bacterial multidrug efflux pumps.

Authors:  Sanath Kumar; Manuel F Varela
Journal:  Int J Mol Sci       Date:  2012-04-10       Impact factor: 6.208

10.  Potential for inhibition of bacterial efflux pumps in multidrug-resistant Vibrio cholera.

Authors:  Manuel F Varela; Sanath Kumar; Guixin He
Journal:  Indian J Med Res       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.